Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THETIS: Deferasirox in Non-transfusion Dependent Thalassemia
NCT01709838Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 4 trial of deferasirox in iron overload, sponsored by Novartis. Started Dec 2012; status: completed.
02
Drugs
deferasirox
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT01709838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01709838.